vs

Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Arhaus, Inc. (ARHS). Click either name above to swap in a different company.

Arhaus, Inc. is the larger business by last-quarter revenue ($364.8M vs $284.0M, roughly 1.3× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 4.1%, a 92.2% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.4% vs 5.1%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 11.2%).

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.

Arhaus, Inc. is an upscale American home furnishings company headquartered in Boston Heights, Ohio. Founded in 1986 with a focus on sustainability and artisanship in product quality, Arhaus provides a diversified assortment of specialty goods and services addressing omnichannel direct-to-consumer and business-to-business residential and commercial operations.

ACAD vs ARHS — Head-to-Head

Bigger by revenue
ARHS
ARHS
1.3× larger
ARHS
$364.8M
$284.0M
ACAD
Growing faster (revenue YoY)
ACAD
ACAD
+4.3% gap
ACAD
9.4%
5.1%
ARHS
Higher net margin
ACAD
ACAD
92.2% more per $
ACAD
96.3%
4.1%
ARHS
Faster 2-yr revenue CAGR
ACAD
ACAD
Annualised
ACAD
17.5%
11.2%
ARHS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACAD
ACAD
ARHS
ARHS
Revenue
$284.0M
$364.8M
Net Profit
$273.6M
$15.1M
Gross Margin
90.8%
38.1%
Operating Margin
6.1%
5.6%
Net Margin
96.3%
4.1%
Revenue YoY
9.4%
5.1%
Net Profit YoY
90.3%
-29.1%
EPS (diluted)
$1.61
$0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACAD
ACAD
ARHS
ARHS
Q4 25
$284.0M
$364.8M
Q3 25
$278.6M
$344.6M
Q2 25
$264.6M
$358.4M
Q1 25
$244.3M
$311.4M
Q4 24
$259.6M
$347.0M
Q3 24
$250.4M
$319.1M
Q2 24
$242.0M
$309.8M
Q1 24
$205.8M
$295.2M
Net Profit
ACAD
ACAD
ARHS
ARHS
Q4 25
$273.6M
$15.1M
Q3 25
$71.8M
$12.2M
Q2 25
$26.7M
$35.1M
Q1 25
$19.0M
$4.9M
Q4 24
$143.7M
$21.3M
Q3 24
$32.8M
$9.9M
Q2 24
$33.4M
$22.2M
Q1 24
$16.6M
$15.1M
Gross Margin
ACAD
ACAD
ARHS
ARHS
Q4 25
90.8%
38.1%
Q3 25
92.2%
38.7%
Q2 25
92.2%
41.4%
Q1 25
91.7%
37.1%
Q4 24
91.6%
40.0%
Q3 24
92.5%
38.6%
Q2 24
92.5%
40.1%
Q1 24
88.8%
39.0%
Operating Margin
ACAD
ACAD
ARHS
ARHS
Q4 25
6.1%
5.6%
Q3 25
12.8%
4.8%
Q2 25
12.2%
13.0%
Q1 25
7.9%
1.7%
Q4 24
59.1%
8.2%
Q3 24
12.6%
3.3%
Q2 24
12.6%
9.5%
Q1 24
7.4%
6.2%
Net Margin
ACAD
ACAD
ARHS
ARHS
Q4 25
96.3%
4.1%
Q3 25
25.8%
3.5%
Q2 25
10.1%
9.8%
Q1 25
7.8%
1.6%
Q4 24
55.4%
6.1%
Q3 24
13.1%
3.1%
Q2 24
13.8%
7.2%
Q1 24
8.0%
5.1%
EPS (diluted)
ACAD
ACAD
ARHS
ARHS
Q4 25
$1.61
$0.11
Q3 25
$0.42
$0.09
Q2 25
$0.16
$0.25
Q1 25
$0.11
$0.03
Q4 24
$0.86
$0.15
Q3 24
$0.20
$0.07
Q2 24
$0.20
$0.16
Q1 24
$0.10
$0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACAD
ACAD
ARHS
ARHS
Cash + ST InvestmentsLiquidity on hand
$177.7M
$253.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.2B
$418.2M
Total Assets
$1.6B
$1.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACAD
ACAD
ARHS
ARHS
Q4 25
$177.7M
$253.4M
Q3 25
$258.0M
$262.2M
Q2 25
$253.6M
$234.8M
Q1 25
$217.7M
$214.4M
Q4 24
$319.6M
$197.5M
Q3 24
$155.1M
$177.7M
Q2 24
$177.1M
$174.2M
Q1 24
$204.7M
$233.2M
Stockholders' Equity
ACAD
ACAD
ARHS
ARHS
Q4 25
$1.2B
$418.2M
Q3 25
$917.3M
$400.4M
Q2 25
$822.4M
$385.6M
Q1 25
$765.2M
$348.8M
Q4 24
$732.8M
$343.7M
Q3 24
$577.2M
$320.6M
Q2 24
$516.7M
$309.3M
Q1 24
$464.0M
$285.6M
Total Assets
ACAD
ACAD
ARHS
ARHS
Q4 25
$1.6B
$1.4B
Q3 25
$1.3B
$1.4B
Q2 25
$1.2B
$1.3B
Q1 25
$1.1B
$1.3B
Q4 24
$1.2B
$1.2B
Q3 24
$976.9M
$1.2B
Q2 24
$914.1M
$1.2B
Q1 24
$855.1M
$1.2B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACAD
ACAD
ARHS
ARHS
Operating Cash FlowLast quarter
$-48.7M
$9.3M
Free Cash FlowOCF − Capex
$-8.8M
FCF MarginFCF / Revenue
-2.4%
Capex IntensityCapex / Revenue
5.0%
Cash ConversionOCF / Net Profit
-0.18×
0.62×
TTM Free Cash FlowTrailing 4 quarters
$59.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACAD
ACAD
ARHS
ARHS
Q4 25
$-48.7M
$9.3M
Q3 25
$74.3M
$46.1M
Q2 25
$64.0M
$34.9M
Q1 25
$20.3M
$46.5M
Q4 24
$40.4M
$31.7M
Q3 24
$63.2M
$31.1M
Q2 24
$25.0M
$47.5M
Q1 24
$29.1M
$36.8M
Free Cash Flow
ACAD
ACAD
ARHS
ARHS
Q4 25
$-8.8M
Q3 25
$73.9M
$28.0M
Q2 25
$20.9M
Q1 25
$18.9M
Q4 24
$13.0M
Q3 24
$63.2M
$4.6M
Q2 24
$11.3M
Q1 24
$10.9M
FCF Margin
ACAD
ACAD
ARHS
ARHS
Q4 25
-2.4%
Q3 25
26.5%
8.1%
Q2 25
5.8%
Q1 25
6.1%
Q4 24
3.7%
Q3 24
25.2%
1.4%
Q2 24
3.6%
Q1 24
3.7%
Capex Intensity
ACAD
ACAD
ARHS
ARHS
Q4 25
5.0%
Q3 25
0.1%
5.3%
Q2 25
3.9%
Q1 25
8.9%
Q4 24
5.4%
Q3 24
0.0%
8.3%
Q2 24
11.7%
Q1 24
8.8%
Cash Conversion
ACAD
ACAD
ARHS
ARHS
Q4 25
-0.18×
0.62×
Q3 25
1.03×
3.77×
Q2 25
2.40×
1.00×
Q1 25
1.07×
9.53×
Q4 24
0.28×
1.49×
Q3 24
1.93×
3.14×
Q2 24
0.75×
2.14×
Q1 24
1.76×
2.44×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACAD
ACAD

Nuplazid$174.4M61%
Daybue$109.6M39%

ARHS
ARHS

Sales Channel Retail$305.7M84%
Sales Channel E Commerce$59.2M16%

Related Comparisons